Efficacy of levosimendan infusion in patients undergoing a left ventricular assist device implant in a propensity score matched analysis of the EUROMACS registry-the Euro LEVO-LVAD study

OBJECTIVES: Early right-sided heart failure (RHF) was seen in 22% of recipients of a left ventricular assist device (LVAD) in the European Registry for Patients with Mechanical Circulatory Support (EUROMACS). However, the optimal treatment of post-LVAD RHF is not well known. Levosimendan has proven...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY 2023-05, Vol.63 (5)
Hauptverfasser: Abdelshafy, Mahmoud, Caliskan, Kadir, Simpkin, Andrew J, Elkoumy, Ahmed, Kimman, Jesse R, Elsherbini, Hagar, Elzomor, Hesham, de By, Theo M.M.H, Gollmann-Tepekoylu, Can, Berchtold-Herz, Michael, Loforte, Antonio, Reineke, David, Schoenrath, Felix, Paluszkiewicz, Lech, Gummert, Jan, Mohacsi, Paul, Meyns, Bart, Soliman, Osama
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!